StockWatch
·
HomeLiveWeekly

Allogene Therapeutics, Inc.

Ticker: 1737287

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-128.37-42.6543.07128.79Q3 FY2022Q1 FY2023Q2 FY2023Q2 FY2023Q3 FY2023Q3 FY2023Q1 FY2024Q1 FY2024

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q3 FY2022Q1 FY2023Q2 FY2023Q2 FY2023Q3 FY2023Q3 FY2023Q1 FY2024Q1 FY2024
PeriodQ1 FY2024Q1 FY2024Q3 FY2023Q3 FY2023Q2 FY2023Q2 FY2023Q1 FY2023Q3 FY2022
INCOME
Revenue0.02+0.0%0.02-50.0%0.04+100.0%0.02-50.0%0.04+100.0%0.02-60.0%0.05+0.0%0.05
Total Income0.02+0.0%0.02-50.0%0.04+100.0%0.02-50.0%0.04+100.0%0.02-60.0%0.05+0.0%0.05
EXPENSES
Expenditure69.53+0.0%69.53+10.3%63.02+0.0%63.02-21.8%80.56+0.0%80.56-18.7%99.12+20.1%82.54
PROFIT
Net Profit-65.00+0.0%-65.00-6.0%-61.32+1.6%-62.29+20.1%-77.99+1.6%-79.23+19.7%-98.70-18.7%-83.15
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.38+0.0%-0.38-2.7%-0.37+0.0%-0.37+30.2%-0.53+1.9%-0.54+20.6%-0.68-17.2%-0.58

Corporate Events

Board MeetingALLO
2026
1Jul

Board Meeting

CEO Transition - David Chang to step down as President and C…

SEC Filing ↗